https://www.reuters.com/article/us-health-coronavirus-astrazeneca-usa-idUSKCN26F10B

8 0

FRANKFURT (Reuters) - AstraZeneca AZN.L is still waiting for the U.S. drug regulator to approve the restart of the clinical trial of its potential COVID-19 vaccine in the United States almost three weeks after it was paused due to safety concerns. FILE PHOTO: A sign at an AstraZeneca site in Macclesfield, Britain, May 19, 2014. REUTERS/Phil Noble/File Photo/File Photo. The U.S. trial of AstraZeneca’s COVID-19 vaccine candidate, initially developed by the University of Oxford, remains on hold while regulators investigate an illness in one of the participants, even after a British study and other programmes outside of the United States have resumed. “We are the sponsor of the U.S. study. W... Full story

24 September

wait